Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for GUARDION HEALTH (GHSI : NSDQ)
 
 • Company Description   
Guardion Health Sciences Inc. is an ocular health sciences company. It develops, formulates and distributes condition-specific medical foods supported by evidence-based protocols, with an initial medical food product which addresses a depleted macular protective pigment. The company also developed a proprietary medical device, the MapcatSF(R), which accurately measures the macular pigment density. Guardion Health Sciences Inc. is based in San Diego, United States.

Number of Employees: 13

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.17 Daily Weekly Monthly
20 Day Moving Average: 2,208,593 shares
Shares Outstanding: 61.43 (millions)
Market Capitalization: $10.15 (millions)
Beta: 0.76
52 Week High: $2.18
52 Week Low: $0.14
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -19.73% -12.37%
12 Week -17.73% -11.09%
Year To Date -74.47% -69.76%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2925 RICHMOND AVENUE SUITE 1200
-
HOUSTON,TX 77098
USA
ph: 800-873-5141
fax: 858-630-5543
scotta@coreir.com http://www.guardionhealth.com
 
 • General Corporate Information   
Officers
Bret Scholtes - President; Chief Executive Officer; and Director
Robert N. Weingarten - Chairman of the Board of Directors
Jeffrey Benjamin - Chief Accounting Officer
Craig Sheehan - Chief Commercial Officer
Mark Goldstone - Director

Peer Information
GUARDION HEALTH (BJCT)
GUARDION HEALTH (CADMQ)
GUARDION HEALTH (APNO)
GUARDION HEALTH (UPDC)
GUARDION HEALTH (IMTIQ)
GUARDION HEALTH (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 40145Q401
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/15/22
Share - Related Items
Shares Outstanding: 61.43
Most Recent Split Date: 3.00 (0.17:1)
Beta: 0.76
Market Capitalization: $10.15 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/15/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.34
Price/Cash Flow: 1.74
Price / Sales: 1.08
EPS Growth
vs. Year Ago Period: 46.15%
vs. Previous Quarter: 30.00%
Sales Growth
vs. Year Ago Period: 923.61%
vs. Previous Quarter: -9.25%
ROE
03/31/22 - -33.56
12/31/21 - -30.46
09/30/21 - -35.94
ROA
03/31/22 - -31.83
12/31/21 - -29.16
09/30/21 - -34.20
Current Ratio
03/31/22 - 11.26
12/31/21 - 10.41
09/30/21 - 7.55
Quick Ratio
03/31/22 - 10.81
12/31/21 - 10.10
09/30/21 - 7.14
Operating Margin
03/31/22 - -114.44
12/31/21 - -149.20
09/30/21 - -239.18
Net Margin
03/31/22 - -263.09
12/31/21 - -342.07
09/30/21 - -282.96
Pre-Tax Margin
03/31/22 - -263.08
12/31/21 - -342.11
09/30/21 - -282.98
Book Value
03/31/22 - 0.49
12/31/21 - 0.91
09/30/21 - 1.50
Inventory Turnover
03/31/22 - 7.18
12/31/21 - 6.85
09/30/21 - 6.01
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©